SCD and hepatocellular carcinoma: discovered that the activation of AMPK can reduce the expression of stearoyl-CoA desaturase-1 (SCD1) and work synergistically with ACSL4, thus increasing the sensitivity of hepatocellular carcinoma to ferroptosis (38).